Authors

  • Ачилова О.У., Каюмов А.А., Каримов Х.Я., Исламов М.С., Обидова М.М.

Keywords:

мобилизация стволовых клеток, трансплантация костного мозга, миеломная болезнь, гемопоэтические клетки, химиотерапия.

References

Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований России и странах СНГ 2007 г. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2009;20 (3) (приложение 1):1–156

Менделеева Л.П. Современное лечение множественной миеломы. Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2009;2(1):64–65

International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of International Myeloma Working Group. Br. J. Haematol. 2003;121(5):749–757

Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009; 23(1): 3–9

Pianko MJ, Terpos E, Roodman GD, et al. Whole–body low–dose computed tomography and advanced imaging techniques for multiple myeloma bone disease. Clin Cancer Res, 2014, 20: 5888–5897

Durie BGM, Salmon SE. A clinical staging system for multiple myeloma: Correlation of measure Myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36(9):842–854

Greipp PR, San Miguel JF, Durie BG, et al. International Staging System for Multiple Myeloma. J Clin Oncol. 2005;23(15):3412–3420

Durie BGM, Harousseau JL, Miguel JS, et al.International uniform response criteria for multiple myeloma. Leukemia. 2006;20 (9):1467–1473

Harousseau JL, Dreyling M. Multiple Myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow–up. Ann Oncol. 2010;21 (suppl.5):155–157

Munshi NC, Anderson KC, Bergsagel L, et al. Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2. Blood. 2011;117(18):4696–4700